2Babon J J,Sabo J K,Soetopo A et al.The SOCS box domain of SOCS3:structure and interaction with the elonginBC-cullin5 ubiquitin ligase[J].J Mol Biol,2008;381(4):928-940.
3Zeng B,Li H,Liu Y et al.Tumor-induced suppressor of cytokine signaling 3 inhibits toll-like receptor 3 signaling in dendritic cells via binding to tyrosine kinase 2[J].Cancer Res,2008;68(13):5397-5404.
4Waiboci L W,Ahmed C M,Mujtaba M G et al.Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site:implications for the development of a SOCS-1 antagonist[J].J Immunol,2007;178(8):5058-5068.
5Starr R,Willson T A,Viney E M et al.A family of cytokine-inducible inhibitors of signaling[J].Nature,1997;387(6636):917-921.
6Endo T A,Masuhara M,Yokouchi M et al.A new protein containing an SH2 domain that inhibits JAK kinases[J].Nature,1997;387(6636):921-924.
7Naka T,Narazaki M,Hirata M et al.Structure and function of a new STAT-induced STAT inhibitor[J].Nature,1997;387(6636):924-929.
8Davey G M,Heath W R,Starr R.SOCS1:a potent and multifaceted regulator of cytokines and cell-mediated inflammation[J].Tissue Antigens,2006;67(1):1-9.
9Chen X P,Losman J A,Cowan S et al.Pim serine/threonine kinases regulate the stability of Socs-1 protein[J].Proc Natl Acad Sci USA,2002;99(4):2175-2180.
10Kamizono S,Hanada T,Yasukawa H et al.The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2[J].J Biol Chem,2001;276(16):12530-12538.
3Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[J]. Nature, 2000, 406(6797): 747-752.
4Kim MJ, Ro JY, Ahn SH, et al. Clinicopathologic significance of the basal-like subtype of breast cancer:a comparison with hormone receptor and Her2/neu-overexpressing phenotypes[J]. Hum Pathol, 2006, 37(9): 1217-1226.
5Saito H, Osaki T, Murakami D, et al. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters [J].J Surg Oncol, 2007, 95(2): 123-128.
6Barbieri G, Rimini E, Costa MA. Effects of human leukocyte antigen(HLA)-DR engagement on melanoma cells[J]. IntJ Oncol, 2011, 38(6): 1589-1595.
7Ambe K,Mori M,Enjoji M.S-100 protein-positive dendritic cells in colorectal adenocarcinoma. Distribution and relation to the clinical prognosis[J]. Cancer, 1989, 63(3): 496-503.
8Kikuchi K, Kusama K, Sano M, et al. Vascular endothelial growth factor and dendritic cells in human squamous cell carcinoma of the oral cavity[J]. Anticancer Res, 2006, 26(3A): 1833-1848.
